Cell & Gene Therapy
Patient-Centered Execution Across Cell, Gene, and RNA Therapeutics
Cell, Gene, and RNA Therapies are shifting the aim of drug development from managing symptoms to delivering durable, potentially curative therapies. But moving a construct from a promising preclinical milestone to a viable commercial asset—whether an ex vivo cell therapy, an in vivo viral vector, or an RNA...